Method of drug formulation based on increasing the affinity of crystalline microparticle surfaces for active agents
First Claim
Patent Images
1. A method for coating a preformed crystalline microparticle with an active agent in a suspension, said method comprising the steps in the sequence set forth of:
- i) obtaining a preformed crystalline diketopiperazine microparticle wherein said preformed crystalline diketopiperazine microparticle does not comprise an active agent;
ii) providing a suspension comprising said preformed crystalline diketopiperazine microparticle, said active agent, and a solvent;
iii) then altering suspension conditions in said provided suspension to modify an energetic interaction between said active agent and said preformed crystalline diketopiperazine microparticle wherein said altering suspension conditions is selected from the group consisting of altering the pH of the solvent, adding monovalent or multivalent ions, altering the polarity, and adding hydrogen bond donors or acceptors to modify a surface property of said preformed crystalline diketopiperazine microparticle wherein said altering step does not include a step of removing said solvent from said suspension; and
iv) adsorbing said active agent onto a surface of said preformed crystalline diketopiperazine microparticle to provide a coating of said active agent on said crystalline microparticle without removing solvent from said suspension;
wherein said altering step causes said adsorbing of said active agent onto a surface of said preformed crystalline diketopiperazine microparticle.
7 Assignments
0 Petitions
Accused Products
Abstract
Methods are provided for coating crystalline microparticles with an active agent by altering the surface properties of the microparticles in order to facilitate favorable association on the microparticle by the active agent. Type of surface properties that are altered by the disclosed methods include by electrostatic properties, hydrophobic properties and hydrogen bonding properties.
-
Citations
18 Claims
-
1. A method for coating a preformed crystalline microparticle with an active agent in a suspension, said method comprising the steps in the sequence set forth of:
-
i) obtaining a preformed crystalline diketopiperazine microparticle wherein said preformed crystalline diketopiperazine microparticle does not comprise an active agent; ii) providing a suspension comprising said preformed crystalline diketopiperazine microparticle, said active agent, and a solvent; iii) then altering suspension conditions in said provided suspension to modify an energetic interaction between said active agent and said preformed crystalline diketopiperazine microparticle wherein said altering suspension conditions is selected from the group consisting of altering the pH of the solvent, adding monovalent or multivalent ions, altering the polarity, and adding hydrogen bond donors or acceptors to modify a surface property of said preformed crystalline diketopiperazine microparticle wherein said altering step does not include a step of removing said solvent from said suspension; and iv) adsorbing said active agent onto a surface of said preformed crystalline diketopiperazine microparticle to provide a coating of said active agent on said crystalline microparticle without removing solvent from said suspension;
wherein said altering step causes said adsorbing of said active agent onto a surface of said preformed crystalline diketopiperazine microparticle. - View Dependent Claims (2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14)
-
-
15. A method for coating a preformed crystalline microparticle with insulin in a suspension, said method comprising the steps in the sequence set forth of:
-
i) dissolving said insulin in a solvent, wherein said insulin comprises insulin, an insulin analog or combinations thereof; ii) obtaining a preformed crystalline diketopiperazine microparticle wherein said preformed crystalline diketopiperazine microparticle does not comprise an active agent; iii) forming a suspension comprising said preformed crystalline diketopiperazine microparticle, said insulin, and said solvent; iv) then altering suspension conditions in said provided suspension to modify the energetic interaction between said insulin and said crystalline microparticle wherein said altering step modifies a surface property of said crystalline microparticle; v) adsorbing said active agent onto a surface of said crystalline diketopiperazine microparticle to provide a coating of said active agent on said crystalline diketopiperazine microparticle without removing solvent from said suspension and wherein said altering step causes said adsorption of insulin onto a surface of said crystalline microparticle; and vi) removing or exchanging said solvent after said adsorbing step. - View Dependent Claims (16)
-
-
17. A method for coating a preformed crystalline microparticle with insulin in a suspension, said method comprising the steps in the sequence set forth of:
-
i) dissolving said insulin in a solvent, wherein said insulin comprises insulin, an insulin analog or combinations thereof; ii) obtaining a preformed crystalline diketopiperazine microparticle in a suspension, wherein said preformed crystalline diketopiperazine microparticle does not comprise an active agent; iii) altering suspension conditions in said preformed crystalline diketopiperazine microparticle suspension wherein said altering step modifies a surface property of said crystalline microparticle; iv) then forming a suspension comprising said surface-modified preformed crystalline diketopiperazine microparticle, said insulin, and said solvent wherein said altering step has modified the energetic interaction between said insulin and said crystalline microparticle; v) then adsorbing said active agent onto a surface of said crystalline microparticle to provide a coating of said active agent on said crystalline microparticle without removing solvent from said suspension and wherein said altering step causes said adsorption of insulin onto a surface of said crystalline microparticle; and vi) removing or exchanging said solvent after said adsorbing step. - View Dependent Claims (18)
-
Specification